caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1881626687

Kevin KnopfM.D.

PRACTICESUTTER BAY HOSPITALSSee all providers at this practice →
Hematology-OncologyBerkeley, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
59
Unique beneficiaries
—
Total services
100
Distinct HCPCS
2
Medicare payment
$10K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 957 Hematology-Oncology providers in CA — bottom quintile (cohort median 4,173).
REFERRAL NETWORK

Where Kevin Knopf's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 17 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Christine Kim
Nurse Practitioner · San Francisco, CA
881,106
Stephanie Jeske
Hematology-Oncology · Santa Clara, CA
60744
MOON, KIRK28118
CARPENTER, HOWARD27117
NPI 127556794326150
Derk Purcell
Diagnostic Radiology · San Francisco, CA
2579
STEVENS, SUSAN2176
Myron Marx
Diagnostic Radiology · San Francisco, CA
1893
ROUNSAVILLE, MARK18379
NPI 13967737431740
Edward Baker
Diagnostic Radiology · San Francisco, CA
17148
GARCIA-KENNEDY, RICHARD1450
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
323
Beneficiaries
—
Total drug cost
$554K
Distinct drugs
12
Brand share
15.8%
Top prescribed drugs
Dexamethasone63 claims
Ondansetron Hcl50 claims
Abiraterone Acetate49 claims
Prednisone48 claims
Hydroxyurea24 claims
QUALITY · MIPS · 2024
Final MIPS score
95.2
Quality
86.9
Cost
72.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.85%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$525
Payment records
1
By payment type
Consulting Fee$525